James Cartwright

Title: Innovations by James Cartwright in Pharmaceutical Development

Introduction

James Cartwright is a notable inventor based in Middlesex, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of highly purified compounds. With a total of 3 patents, his work has advanced the production and purification methods of important pharmaceutical ingredients.

Latest Patents

Cartwright's latest patents include methods for producing highly purified batches of pharmaceutical grade migalastat and methods for producing Active Pharmaceutical Ingredient (API) grade migalastat hydrochloride. Additionally, he has developed methods for purifying intermediate grade migalastat hydrochloride. His work also encompasses the production of [(2R,3S,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride (lucerastat hydrochloride) and other 1-deoxygalactonojirimycin compounds, along with methods for purifying these compounds.

Career Highlights

James Cartwright is currently associated with Amicus Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in the production of pharmaceutical compounds has positioned him as a key figure in his field.

Collaborations

Throughout his career, Cartwright has collaborated with notable colleagues such as Clive King and Wendy Cross. These partnerships have further enhanced his contributions to pharmaceutical research and development.

Conclusion

James Cartwright's work in pharmaceutical innovations has led to significant advancements in the production and purification of essential compounds. His patents reflect a commitment to improving pharmaceutical processes and enhancing the quality of medical treatments.